Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium

Anesthesiology

Volumn 107, Issue 1, 2007, Pages 166-167

  Rocq, Nicolas ^a,c   Favier, Jean Christophe ^b   Plancade, David ^b   Steiner, Thierry ^b   Mertes, Paul Michel ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Hopital d'Instruction des Armees Legouest   (France)

^c CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; AMMONIA; CIMETIDINE; GLYPRESSINE; HISTAMINE; HYDROXYZINE; IMMUNOGLOBULIN E; PROPOFOL; REMIFENTANIL; RINGER LACTATE SOLUTION; SUXAMETHONIUM; SUXAMETHONIUM IODIDE; TERLIPRESSIN; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; BLOOD SAMPLING; BRONCHOSPASM; CASE REPORT; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; FLUID RESUSCITATION; GASTROESOPHAGEAL REFLUX; HEART ARREST; HEART VENTRICLE FIBRILLATION; HISTAMINE BLOOD LEVEL; HUMAN; HYPOKINESIA; INFUSION; INGUINAL HERNIA; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; VENTILATOR;

ANAPHYLAXIS; ANESTHESIA, GENERAL; CARDIOPULMONARY RESUSCITATION; DRUG RESISTANCE; EPINEPHRINE; HEART ARREST; HERNIA, INGUINAL; HUMANS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; NEUROMUSCULAR DEPOLARIZING AGENTS; SUCCINYLCHOLINE; VASOCONSTRICTOR AGENTS;

EID: 34250861242     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000268275.41074.42     Document Type: Article

References (11)

1. Heytman M, Rainbird A: Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: Case studies and review. Anaesthesia 2004; 59:1210-5
2. Kill C, Wranze E, Wulf H: Successful treatment of severe anaphylactic shock with vasopressin. Int Arch Allergy Immunol 2004; 134:260-1
3. Schummer W, Schummer C, Wippermann J, Fuchs J: Anaphylactic shock: Is vasopressin the drug of choice? ANESTHESIOLOGY 2004; 101:1025-7
4. Williams SR, Denault AY, Pellerin M, Martineau R: Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth 2004; 51:169-72
5. Mertes PM, Laxenaire MC, Alla F: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. ANESTHESIOLOGY 2003; 99:536-45
6. Laxenaire MC: Epidemiology of anesthetic anaphylactoid reactions: Fourth multicenter survey (July 1994-December 1996) [in French]. Ann Fr Anesth Reanim 1999; 18:796-809
7. Mertes PM, Pinaud M: What are the physiopathological mechanisms? How can severe anaphylactoid reactions be explained [in French]. Ann Fr Anesth Reanim 2002; 21:55s-72s
8. Jacobsen J, Lindekaer AL, Ostergaard HT, Nielsen K, Ostergaard D, Laub M, Jensen PF, Johannessen N: Management of anaphylactic shock evaluated using a full-scale anaesthesia simulator. Acta Anaesthesiol Scand 2001; 45:315-9
9. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-10
10. Eyraud D, Brabant S, Nathalie D, Fleron MH, Gilles G, Bertrand M, Coriat P: Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 1999; 88:980-4
11. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talance N, Longrois D, Mertes PM: Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. ANESTHESIOLOGY 2006; 104:734-41